VHH-based chimeric antigen receptor T cells against CD70 to eliminate primary and rechallenge renal cell carcinoma tumors in preclinical study.

被引：0
|
作者：
Jiang, Pengfei [1 ]
Xiong, Qinghui [1 ]
Wang, Haiying [1 ]
Deng, Tian [1 ]
机构：
[1] HRAIN Biotechnol, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14540
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment
    Xiong, Qinghui
    Wang, Haiying
    Shen, Qiushuang
    Wang, Yan
    Yuan, Xiujie
    Lin, Guangyao
    Jiang, Pengfei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [2] CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma
    Park, Yuk Pheel
    Jin, Linchun
    Bennett, Katie B.
    Wang, Dunrui
    Fredenburg, Kristianna M.
    Tseng, Jennifer E.
    Chang, Lung-Ji
    Huang, Jianping
    Chan, Edward K. L.
    ORAL ONCOLOGY, 2018, 78 : 145 - 150
  • [3] CD70 HIT T cells overcome tumor antigen heterogeneity in renal cell carcinoma
    Hanina, Sophie A.
    Lopez, Michael
    Zhao, Huiyong
    Vinagolu, Rajasekhar
    Kotecha, Ritesh
    Hakimi, A. Ari
    Healey, John H.
    Mansilla-Soto, Jorge
    Sadelain, Michel
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
    Panowski, Siler H.
    Srinivasan, Surabhi
    Tan, Nguyen
    Tacheva-Grigorova, Silvia K.
    Smith, Bryan
    Mak, Yvonne S. L.
    Ning, Hongxiu
    Villanueva, Jonathan
    Wijewarnasuriya, Dinali
    Lang, Shanshan
    Melton, Zea
    Ghosh, Adit
    Dusseaux, Mathilde
    Galetto, Roman
    Heyen, Jonathan R.
    Sai, Tao
    Van Blarcom, Thomas
    Chaparro-Riggers, Javier
    Sasu, Barbra
    CANCER RESEARCH, 2022, 82 (14) : 2610 - 2624
  • [5] Evaluation of CD70 Chimeric Antigen Receptor T (CAR-T) Cells As a Potential Treatment for Non-Hodgkin's Lymphoma: A Preclinical Study
    Jiang, Pengfei
    Xiong, Qinghui
    Yuan, Xiujie
    Zhang, Haoyu
    Shen, Qiushuang
    Wang, Yang
    Gong, Yiwei
    BLOOD, 2023, 142
  • [6] T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts
    Nasiri, Fatemeh
    Kozani, Pooria Safarzadeh
    Rahbarizadeh, Fatemeh
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Preclinical development and evaluation of allogeneic CAR T cells targeting CD70 for the treatment of renal cell carcinoma.
    Panowski, Siler
    Srinivasan, Surabhi
    Nguyen Tan
    Tacheva-Grigorova, Silvia
    Smith, Bryan
    Mak, Yvonne
    Ning, Hongxiu
    Villanueva, Jonathan
    Wijewarnasuriya, Dinali
    Lang, Shanshan
    Melton, Zea
    Ghosh, Adit
    Dusseaux, Mathilde
    Galetto, Roman
    Heyen, Jonathan
    Sai, Tao
    Van Blarcom, Thomas
    Chaparro-Riggers, Javier
    Sasu, Barbra
    CANCER RESEARCH, 2022, 82 (12)
  • [8] A VHH-Based Anti-MUC1 Chimeric Antigen Receptor for Specific Retargeting of Human Primary T Cells to MUC1-Positive Cancer Cells
    Rajabzadeh, Alireza
    Rahbarizadeh, Fatemeh
    Ahmadvand, Davoud
    Salmani, Maryam Kabir
    Hamidieh, Amir Ali
    CELL JOURNAL, 2021, 22 (04) : 502 - 513
  • [9] Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC
    Kolluri, Aarti
    Li, Dan
    Li, Nan
    Duan, Zhijian
    Roberts, Lewis R.
    Ho, Mitchell
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (02) : E0022
  • [10] Use of CD70 Targeted Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Acute Myeloid Leukemia (AML)
    Leick, Mark
    Scarfo, Irene
    Choi, Bryan D.
    Larson, Rebecca
    Bouffard, Amanda A.
    Castano, Ana
    Cabral, Maria L.
    Schmidts, Andrea
    Frigault, Matthew J.
    Maus, Marcela V.
    BLOOD, 2019, 134
12345